* Please be kindly noted that our services and products can only be used for research to organizations or companies and not intended for any clinical or individuals.
In PROTAC development, the linker is not simply a passive connector between the target protein ligand and E3 ligase ligand. Its rigidity, length, vector orientation, polarity, and attachment site can determine whether a productive POI-PROTAC-E3 ternary complex is formed, how long the complex remains stable, and whether the degrader achieves selective protein degradation in cellular systems. Rigid linkers, including aromatic, heteroaromatic, alkyne, cycloalkyl, piperazine, triazole, and spirocyclic motifs, are increasingly used to pre-organize PROTAC geometry, reduce conformational entropy loss, and improve structure-activity relationship (SAR) interpretability.
BOC Sciences provides specialized rigid linker design services for PROTAC programs that require conformational control, improved ternary complex geometry, reduced nonspecific flexibility, and data-guided linker optimization. As part of our broader linker design and optimization services, we integrate computational modeling, medicinal chemistry, linker library design, synthesis, analytical characterization, and in vitro degradation evaluation to help pharmaceutical and biotechnology teams identify linker architectures that match their target, E3 ligase, and research objectives.
Request a Consultation Explore ServicesWe analyze the geometry of the POI ligand, E3 ligase ligand, binding vectors, exposed solvent channels, and known SAR constraints to determine whether a rigid, semi-rigid, or hybrid linker strategy is suitable. For early-stage programs, we help clients define linker hypotheses before synthesis, reducing blind linker-length screening and improving decision quality.
BOC Sciences designs and synthesizes focused rigid linker libraries containing phenyl, biphenyl, pyridine, triazole, piperazine, alkyne, cyclopropyl, cyclobutyl, bicyclic, and spirocyclic fragments. For clients requiring ready-to-use building blocks, our PROTAC linker portfolio can support rapid analog generation and customized linker expansion.
Rigid linker performance depends strongly on where and how the linker exits both ligands. We evaluate exit vectors, synthetic handles, steric accessibility, and polar group exposure to determine optimal linkage sites. Our team can combine rigid linker design with linker binding site selection and design to improve spatial complementarity between POI and E3 ligase surfaces.
Our modeling team applies molecular docking for protein-ligand, conformational search, ternary complex modeling, and linker pose filtering to prioritize rigid linkers that can orient the two ligands productively. This approach is especially useful when flexible PEG or alkyl linkers produce multiple inactive poses or inconsistent degradation data.
Full rigidity is not always optimal. We design hybrid linkers that combine a conformationally directing rigid motif with limited flexible segments, such as PEG, alkyl, amide, or methylene spacers. This helps balance ternary complex pre-organization, solubility, permeability, synthetic accessibility, and target-dependent conformational tolerance.
We support synthesis of rigid linker-containing PROTAC analogs, analytical confirmation by LC-MS, HRMS, NMR, and HPLC, and SAR interpretation based on degradation potency, binding behavior, solubility, and stability. The resulting data help clients identify whether linker rigidity improves degradation efficiency or over-constrains productive ternary complex formation.
Need to Move Beyond Empirical Linker Screening?
BOC Sciences helps you design rigid and semi-rigid PROTAC linkers based on target geometry, ternary complex behavior, and SAR data.
We use computational approaches to evaluate linker geometry before synthesis, helping teams prioritize rigid linker chemotypes with stronger structural rationale.
For linker candidates requiring deeper analysis, we apply molecular dynamics simulation to evaluate complex stability, linker strain, protein-protein interface persistence, and possible water-mediated interactions.
Our medicinal chemistry team designs and synthesizes rigid linker motifs with tunable geometry, polarity, hydrogen-bonding capacity, and synthetic handles.
Rigid linker optimization requires more than binary binding confirmation. We combine binding affinity measurement with ternary complex studies to understand whether a linker improves productive proximity and cooperativity.
We connect linker design hypotheses with functional degradation outcomes through PROTAC in vitro evaluation, helping clients identify rigid linker analogs with meaningful cellular activity.
Rigid linkers can improve pre-organization but may also affect solubility, permeability, and aggregation tendency. We evaluate key physicochemical properties to support practical degrader optimization.
Improved Ternary Complex Pre-Organization
Rigid linkers can reduce the conformational freedom of a PROTAC molecule, helping the POI ligand and E3 ligase ligand approach each other with a more favorable spatial orientation.
Clearer SAR Interpretation
Compared with highly flexible linkers, rigid motifs often provide more interpretable SAR because each analog samples fewer conformations, making it easier to connect structure with degradation outcome.
Potential Selectivity Enhancement
By controlling POI-E3 orientation, rigid linkers may help stabilize productive protein-protein contacts that favor selective degradation of specific targets or isoforms.
Reduced Entropic Penalty
Pre-organized linkers can reduce the energetic cost of adopting a productive bound conformation, which may improve ternary complex formation and degradation potency when the geometry is well matched.

Aromatic and Heteroaromatic Linkers
Phenyl, biphenyl, pyridyl, pyrimidyl, and other aromatic systems provide directional rigidity and can tune polarity, π-surface exposure, and binding vector geometry. These motifs are useful when a defined linear or angled linker trajectory is required.
Triazole and Click-Derived Linkers
Triazole linkers introduce rigidity, polarity, and hydrogen-bonding potential while providing efficient synthetic accessibility. They are frequently explored when rapid linker analog generation is required across multiple POI and E3 ligand combinations.
Piperazine-Containing Linkers
Piperazine can add conformational restriction and polarity modulation, supporting rigid-flexible hybrid designs. Its local chemical environment must be carefully tuned because substitution patterns can alter basicity, solubility, and cellular performance.
Alkyne and Linear Rigid Linkers
Alkynes provide a compact linear element that can extend linker distance without introducing excessive rotatable bonds. They are often used to test whether a more defined ligand-to-ligand vector improves ternary complex alignment.
Cycloalkyl and Bicyclic Linkers
Cyclopropyl, cyclobutyl, cyclohexyl, bicyclic, and spirocyclic motifs offer three-dimensional rigidity and can help reshape linker topology when flat aromatic systems are not optimal for target geometry or physicochemical balance.
Rigid-Flexible Hybrid Linkers
Hybrid linkers combine rigid direction-setting motifs with short flexible segments to preserve adaptability. This design is valuable when the ternary complex requires both orientation control and limited conformational adjustment.
Project Consultation and Data Review
We review the POI, E3 ligase, ligand structures, existing linker data, degradation profile, binding information, and project objectives to determine whether rigid linker design is scientifically justified.
Binding Vector and Geometry Analysis
Our team evaluates available structures, docking poses, solvent-exposed ligand positions, linker attachment sites, and steric constraints to identify feasible linker trajectories.
Rigid Linker Hypothesis Generation
We design multiple linker hypotheses, including fully rigid, semi-rigid, and rigid-flexible hybrid options, with defined rationales for length, angle, polarity, and synthetic accessibility.
Computational Prioritization
Candidate linkers are filtered through conformational search, docking, ternary complex modeling, and physicochemical evaluation to prioritize analogs for synthesis.
Synthesis of Rigid Linker PROTAC Analogs
Selected analogs are synthesized using suitable coupling, click, amide formation, heterocycle construction, or fragment assembly strategies, followed by analytical confirmation.
Binding and Ternary Complex Testing
We evaluate target binding, E3 ligase binding, and POI-PROTAC-E3 ternary complex behavior through appropriate biochemical and biophysical assays, including PROTAC ternary complex assay when required.
Functional Degradation Evaluation
Promising analogs are tested in relevant cellular systems to compare degradation potency, Dmax, DC50, time dependence, and concentration-response behavior.
SAR Interpretation and Next-Round Design
We integrate modeling, synthesis, binding, degradation, and physicochemical data to recommend the next linker optimization cycle or nominate lead rigid linker candidates.
Start Your Rigid PROTAC Linker Optimization Project
Work with BOC Sciences to transform linker design from trial-and-error into a structure-informed degrader optimization strategy.
Integrated PROTAC Expertise
Our team supports PROTAC design services from ligand selection to linker optimization, synthesis, and functional evaluation, allowing rigid linker work to be integrated into the full degrader design process.

Structure-Guided Design Mindset
We do not treat rigid linker design as simple scaffold replacement. Each linker proposal is connected to a specific hypothesis about binding vector, ternary complex geometry, and degradation mechanism.
Diverse Rigid Linker Chemistry
We support aromatic, heteroaromatic, triazole, piperazine, alkyne, cycloalkyl, bicyclic, spirocyclic, and hybrid linker chemotypes, enabling broad exploration of conformationally restricted PROTAC space.
Data-Driven SAR Iteration
Linker analogs are evaluated using binding, degradation, and physicochemical data rather than potency alone, helping clients understand why a rigid linker succeeds or fails.
Physicochemical Balance
We evaluate whether increased rigidity affects solubility, stability, aggregation, and cellular exposure, and can integrate solubility and stability assessment into the linker optimization plan.
Flexible Collaboration Models
Clients may request single-step linker design, focused linker library synthesis, computational prioritization, full PROTAC analog development, or integrated degradation evaluation according to project stage.
Improving Weak or Inconsistent Degradation
When a PROTAC binds both POI and E3 ligase but shows weak degradation, rigid linker design can test whether a more defined spatial arrangement improves productive ternary complex formation.
Optimizing Kinase-Targeting PROTACs
Kinase degraders often require precise positioning to achieve selectivity and strong ternary complex cooperativity. Rigid or semi-rigid linkers can help tune orientation across active and inactive kinase conformations.
Enhancing Selectivity Across Protein Families
Rigid linkers may help discriminate among homologous proteins by stabilizing protein-protein contacts that are favorable for one target but less favorable for related proteins.
Reducing Excessive Linker Flexibility
For PROTACs with long PEG or alkyl linkers, rigid motifs can reduce the number of inactive conformations and help clarify which linker geometry supports degradation.
Building Focused SAR Libraries
Rigid linker motifs allow systematic comparison of linker length, angle, polarity, and exit vector, generating focused SAR libraries with clear design logic.
Supporting Targeted Protein Degradation Tool Development
Rigid linker-containing PROTACs can serve as high-quality chemical biology tools for exploring target dependency, protein function, and ubiquitin-proteasome pathway engagement.
Project Background
A biotechnology client was developing a BRD4-targeting PROTAC based on a BET ligand and a VHL ligand. The original analog contained a flexible PEG-alkyl linker and showed measurable BRD4 binding, but cellular degradation was inconsistent across cancer cell models. The client needed a rational linker redesign strategy to improve degradation potency and generate a clearer SAR path.
Technical Challenges
Modeling suggested that the flexible linker sampled multiple inactive poses, and small changes in linker length produced unpredictable degradation outcomes. The client also observed reduced cellular activity for several highly polar linker analogs, indicating that conformational control and physicochemical balance needed to be addressed together.
BOC Sciences Solutions
Project Outcomes
BOC Sciences identified a phenyl-triazole hybrid linker analog that achieved stronger BRD4 degradation than the original flexible linker series. Among 12 synthesized candidates, three showed improved degradation profiles, and the lead analog reached low-nanomolar DC50 with higher Dmax and more consistent activity across tested cellular systems. The client obtained a focused SAR map showing that moderate rigidity with one flexible hinge was superior to both fully flexible and fully rigid designs.
Project Background
A pharmaceutical discovery group was optimizing a BTK degrader based on a covalent BTK ligand and a CRBN ligand. The initial PROTAC showed strong BTK engagement but only moderate degradation. The client suspected that linker conformation limited productive POI-E3 proximity and requested a rigid linker redesign campaign.
Technical Challenges
The covalent BTK ligand imposed a constrained attachment vector, while the CRBN ligand tolerated only limited modification. Fully rigid aromatic linkers were predicted to create steric conflict, whereas long flexible linkers reduced SAR clarity and increased aggregation risk.
BOC Sciences Solutions
Project Outcomes
The best semi-rigid piperazine linker analog improved BTK degradation compared with the client's flexible linker reference and showed a clearer concentration-response relationship. Out of 18 designed analogs, five were advanced for synthesis, and two demonstrated improved degradation efficiency. The lead molecule combined a piperazine core with a short methylene spacer, balancing conformational control, solubility, and cellular activity. The client used the resulting SAR package to guide the next round of degrader optimization.
Rigid linkers are especially valuable when a PROTAC project requires precise control over the spatial orientation between the target protein ligand and the E3 ligase ligand. They are often considered when flexible linkers produce inconsistent degradation, weak ternary complex formation, or poor structure–activity relationships. By reducing excessive conformational freedom, rigid linkers can help improve productive binding geometry and enhance degradation selectivity. BOC Sciences supports rigid linker design by evaluating target topology, ligand exit vectors, E3 ligase selection, linker length, polarity, and synthetic accessibility to build focused linker libraries for systematic optimization.
No. Rigid linkers are not universally superior to flexible linkers. Their main advantage is conformational restriction, which can reduce entropic penalties and favor a productive ternary complex. However, excessive rigidity may prevent the target protein and E3 ligase from adopting the correct proximity or orientation. Flexible linkers may offer broader conformational sampling and improved solubility, but they can also introduce inactive conformations. In many projects, the best solution is a semi-rigid linker strategy that balances structural control, molecular flexibility, physicochemical properties, and degradation performance.
Useful starting information includes the target protein, selected E3 ligase, known target ligand, E3 ligand, proposed attachment sites, preliminary degradation data, cell model, solubility observations, and any available structure–activity relationship data. If clients have molecular docking results, binding-site information, or previous linker screening results, these can further guide linker geometry and length selection. BOC Sciences integrates computational modeling, medicinal chemistry analysis, synthetic feasibility assessment, and functional assay planning to prioritize linker designs that are more likely to support productive ternary complex formation and efficient target degradation.
Rigid linker performance should be assessed through multiple parameters rather than binding affinity alone. Key readouts may include target degradation level, DC50, Dmax, hook effect profile, selectivity, solubility, chemical stability, cell permeability, and overall cellular activity. For the same target protein–E3 ligase pair, BOC Sciences can design a structured linker matrix comparing different aromatic units, alkynyl spacers, cycloalkyl motifs, heterocyclic segments, and semi-rigid hinge structures. These candidates can then be evaluated through in vitro degradation assays, Western blot analysis, cellular activity testing, and LC-MS-based characterization to identify the most promising linker architecture.
BOC Sciences reduces rigid linker optimization risk through an iterative workflow that connects structural hypothesis, focused linker library design, synthesis, functional testing, and data-driven redesign. Instead of replacing linkers mechanically, we design project-specific rigid and semi-rigid structures based on target surface features, ligand exit direction, E3 recruitment requirements, and experimental feedback. For projects with insufficient degradation, poor selectivity, or unbalanced physicochemical properties, we can further adjust linker length, angle, polarity, rigidity, and attachment position. This systematic approach helps clients identify PROTAC candidates with improved degradation activity and development potential.
Clearer Linker SAR
"Our flexible linker series produced confusing degradation results. BOC Sciences helped us design a smaller but more informative rigid linker matrix, and the SAR became much easier to interpret."
— Principal Scientist at a US-based Biotech Firm
Strong Computational Guidance
"The team did not simply suggest common linkers. They connected every rigid linker proposal to a specific ternary complex hypothesis, which helped our internal team make faster design decisions."
— Director of Medicinal Chemistry at a European Pharmaceutical Company
Balanced Chemistry and Biology
"BOC Sciences understood that linker rigidity must be balanced with solubility and cellular performance. Their integrated chemistry and assay support allowed us to identify a practical lead linker."
— Senior Research Manager at an Oncology Discovery Group
Efficient Analog Prioritization
"Instead of synthesizing dozens of random linker analogs, BOC Sciences prioritized a focused set of rigid and semi-rigid designs. This saved resources and gave us actionable degradation data."
— Head of Targeted Protein Degradation at a UK Biotech
* PROTAC® is a registered trademark of Arvinas Operations, Inc., and is used under license.
Please contact us with any specific requirements and we will get back to you as soon as possible.